Develops drugs for immune-mediated diseases like psoriasis and lupus.
Jun 2026Revenue $7.40M/yrExpenses $466M/yr
No trendCash runway ≈ 2 months from Jun 2026
Figures by year
When will Alumis be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $7.40M and expenses $466M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $24.1M | $478M | −$454M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.